IART
USDIntegra LifeSciences Holdings Corporation Common Stock
वास्तविक समय मूल्य
मूल्य चार्ट
मुख्य मीट्रिक्स
बाजार मीट्रिक्स
खुलना
$11.390
उच्च
$11.600
कम
$11.220
मात्रा
0.19M
कंपनी के मौलिक सिद्धांत
बाजार पूंजीकरण
880.2M
उद्योग
चिकित्सा उपकरण
देश
United States
ट्रेडिंग आँकड़े
औसत मात्रा
1.22M
एक्सचेंज
NMS
मुद्रा
USD
52-सप्ताह रेंज
संबंधित समाचार
Truist Securities Reiterates Hold on Integra Lifesciences, Lowers Price Target to $13
Truist Securities analyst Ravi Misra reiterates Integra Lifesciences with a Hold and lowers the price target from $15 to $13.
Citigroup Maintains Sell on Integra Lifesciences, Lowers Price Target to $11
Citigroup analyst Joanne Wuensch maintains Integra Lifesciences with a Sell and lowers the price target from $12 to $11.
JP Morgan Maintains Underweight on Integra Lifesciences, Raises Price Target to $13
JP Morgan analyst Robbie Marcus maintains Integra Lifesciences with a Underweight and raises the price target from $12 to $13.
Integra LifeSciences Reports Third Quarter 2025 Financial Results
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, today reported financial results for the third quarter ending
संबंधित स्टॉक
अपडेट रहें
मूल्य अलर्ट सेट करें, AI विश्लेषण अपडेट और वास्तविक समय बाजार समाचार प्राप्त करें।